Home » Newsletters » BioWorld Science

BioWorld Science

July 23, 2008

View Archived Issues

New antiinfective agents disclosed in recent Novartis patent

Recent patents describe new treatment options for cardiovascular diseases

Combined radiation therapy with GMX-1777 may be useful in head and neck cancer

Gamida-Cell enters agreement with Amgen for use of cytokines in manufacture of StemEx

Pain Therapeutics reports results from phase I clinical trial of melanin-binding antibody

Alnylam grants InterfeRx license to Calando for RNAi therapeutics

2008 highlights at Lorus Therapeutics

Gilead Sciences offers Q2 overview

Antisense presents an update on the company's activities

Combretastatin A4 safe and effective in patients with anaplastic thyroid cancer

Novel analgesic agents reported in recent patent literature

Rituximab plus IVIG effective in desensitization for kidney transplantation

Nanoparticle-mediated drug delivery suppresses metastasis in murine cancer models

GeneNews launches blood-based molecular colorectal cancer test, ColonSentry

BioMarin and Summit collaborate on Duchenne muscular dystrophy program

Living Cell Technologies reports clinical benefit with DiabeCell in diabetes trial

Opexa reports results from phase I/II extension study with Tovaxin in MS

NicOx completes enrollment in 2 phase I trials of naproxcinod in hypertensive OA patients

Cenix and Regulus enter research agreement for miRNA-targeted drug discovery

Cell Therapeutics to meet with FDA in September 2008 to discuss sBLA for Zevalin

Roche to acquire Mirus for USD 125 million

Amorfix and UBC enter Alzheimer's research collaboration based on SOD1 protein

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...